-
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares
jumped 49.3 percent to $27.46 after the company reported positive topline Phase 2 results for ralinepag in patients with
pulmonary arterial hypertension.
-
Halcon Resources Corporation (NYSE: HK) shares surged
37 percent to $6.11 after the company reported the sale of its operated Williston Basin assets for $1.4 billion.
-
Amicus Therapeutics, Inc. (NASDAQ: FOLD) shares
climbed 23.8 percent to $12.70. The U.S. FDA confirmed that Amicus Therapeutics may submit NDA for migalastat for Fabry
disease.
-
Ocular Therapeutix Inc (NASDAQ: OCUL) surged 19.1
percent to $7.73 after the company reported submission of amendment to potentially extend review for DEXTENZA NDA.
-
ENDRA Life Sciences Inc. (NASDAQ: NDRA) shares
rose 18.4 percent to $3.79.
-
TherapeuticsMD Inc (NYSE: TXMD) shares surged 15
percent to $5.52. Oppenheimer upgraded TherapeuticsMD from Perform to Outperform.
-
Rent-A-Center Inc (NASDAQ: RCII) shares gained
10.7 percent to $12.28. Vintage Capital is said to have proposed to acquire Rent-A-Center for $15.00 per share or approximately
$800 million, according to a letter as reported by Reuters.
-
Evogene Ltd (NASDAQ: EVGN) gained 9 percent to
$5.34. Evogene disclosed that it has reached a milestone for its partnership with Monsanto. The company also announced the
completion of the candidate gene discovery stage.
-
Simulations Plus, Inc. (NASDAQ: SLP) shares
climbed 8.5 percent to $13.99 on strong quarterly earnings.
-
Sientra Inc (NASDAQ: SIEN) gained 8.3 percent to
$10.29. Stephens & Co. initiated coverage of Sientra with an Overweight rating.
-
Enanta Pharmaceuticals Inc (NASDAQ: ENTA) surged
7.5 percent to $35.91.JMP Securities upgraded Enanta Pharmaceuticals from Market Perform to Market Outperform.
-
Golden Ocean Group Ltd (NASDAQ: GOGL) shares rose
6.2 percent to $6.52 after gaining 4.24 percent on Monday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.